As of April 30, 2022, the Board of SK bioscience is composed of a total of seven directors (two executive directors, four outside directors, and one other non-executive director)with the outside directors accounting for 57%. Director Ik-Hwan Kwon serves as the Chairperson of the Board and is expected to contribute to the realization of Board management based on his abundant experience in the legal field.
SK bioscience appointed outside directors in consideration of career, gender diversity, and independence. The Outside Director Candidate Recommendation Committee, which is made up of all outside directors, nominates outside director candidates in full consideration of the legal qualifications required for an outside director, diversity, and expertise. Once a candidate is confirmed after a review by the Board, an agenda for appointing outside directors is presented at the annual general meeting, where outside directors are appointed after a vote.
Our Board consists of executives(CEO Jae Yong Ahn, Director Kwang-Hyun Jun), a vaccine expert (Director Hun Kim), a health and administration expert(Director Chang-Jin Moon), a HR specialist (Director Mi-Jin Jo), a finance and accounting expert (Director Jeong-Wook Choi), and a legal expert (Director Ik-Hwan Kwon). In addition, we improved gender diversity within the Board by appointing Mi-Jin Jo as an outside director in 2020.
In accordance with Article 382 of the Commercial Act, directors are appointed at the General Meeting of Shareholders and the Board consists of up to 10 directors, as specified in the Articles of Incorporation.